Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |